ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 20 Issue : 2
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients [Anatol J Cardiol]
Anatol J Cardiol. 2018; 19(2): 123-129 | DOI: 10.14744/AnatolJCardiol.2017.8097  

Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients

Zhong- Ling Zhuo, Hai- Peng Xian, Yan Long, Chang Liu, Yuan- Yuan Sun, Yin- Ting Ma, Hua Gao, Jing- Zhong Zhao, Xiao- Tao Zhao
Department of Clinical Laboratory, Peking University People’s Hospital; Beijing-China

Objective: To investigate the association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance (CR) in patients with cardiovascular disease in Beijing district.
Methods: In total, 325 patients were enrolled in the study, including 101 experimental group patients and 224 control group patients. The experimental group was divided into CR group (n=30) and non-CR group (n=71) according to the adenosine diphosphate (ADP)-induced platelet inhibition rate in thromboelastography (TEG) (ADP-induced platelet inhibition rate of <30% was defined as CR and rate of 30%–100% was defined as non-CR). Genotypes, including CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*17, and ABCB1, were determined using time-of-flight mass spectrometry (Clin-TOF) and Sanger sequencing in all patients.
Results: In the experimental group, carriers of CYP2C19 heterozygous (*1/*2, n=46; *1/*3, n=7), and mutation homozygous (*2/*2, n=7; *2/*3, n=3; *3/*3, n=0) genotypes showed significantly lower ADP-induced platelet inhibition rates than noncarriers (*1/*1, n=38; p=0.035 and 0.001, respectively); the carriage of mutant CYP2C19*2 or *3 allele was significantly associated with an increased risk of CR. In contrast, carriers of ABCB1 heterozygous (TC, n=50) showed significantly lower ADP-induced platelet inhibition rates than noncarriers (CC, n=39, p=0.097), and there was no significant correlation between ABCB1 genotypes and higher CR risk.
Conclusion: The carriage of CYP2C19*2 or *3 mutant allele was significantly associated with attenuated platelet response to clopidogrel and increased CR risk. The carriage of ABCB1 mutant allele was not significantly associated with CR risk.

Keywords: CYP2C19, ABCB1 gene, polymorphism, clopidogrel resistance, adenosine diphosphate, induced platelet inhibition rate


Zhong- Ling Zhuo, Hai- Peng Xian, Yan Long, Chang Liu, Yuan- Yuan Sun, Yin- Ting Ma, Hua Gao, Jing- Zhong Zhao, Xiao- Tao Zhao. Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients. Anatol J Cardiol. 2018; 19(2): 123-129

Corresponding Author: Xiao- Tao Zhao, China


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2018 Turkish Society of Cardiology